TrustTSC Study: Enrolling children and adults with TSC-associated seizures

The TrustTSC trial is exploring whether treatment with investigational ganaxolone can reduce the frequency of seizures associated with TSC in children and adults. The study is currently enrolling in the US, France, Italy, Spain and Germany with future plans for the UK and Belgium.
Dr. Ian Miller, MD, Vice President, Clinical Development, Marinus Pharmaceuticals and Dr. David Ritter, MD, PhD, Attending Neurologist and Assistant Professor, Cincinnati Children's Hospital Medical Center provide an overview on clinical trials, the TSC treatment paradigm, the unmet medical need in TSC, the TrustTSC trial, and how patients and families can talk to their doctors about participating.
This webinar was sponsored by Marinus Pharmaceuticals.
Download the presentation: ow.ly/nlrQ50NVfqg

[@salahfulmor9458]

Seizures help me please keto diet low down better Epilepsy tomor brain heal healthy

[@salahfulmor9458]

Seizures Epilepsy tomor brain TSC Work seizures no
Seizures medicine

[@salahfulmor9458]

New

[@salahfulmor9458]

Seizures

[@salahfulmor9458]

Medicine

[@salahfulmor9458]

Blood

[@salahfulmor9458]

Body